Bowel Obstruction & GLP-1 Medications

Bowel obstruction occurs when a blockage in the small or large intestine prevents food, fluids, and gas from passing through normally. Symptoms include severe cramping abdominal pain, distension, vomiting, and inability to pass stool or gas. It is a medical emergency that can lead to tissue death (necrosis) if untreated.

GLP-1 medications slow intestinal motility as part of their mechanism of action. In some patients, this slowing becomes severe enough to cause partial or complete bowel obstruction, or ileus — a condition where the intestines temporarily stop contracting altogether. Emergency surgery may be required to remove damaged bowel tissue.

Lawsuits allege that manufacturers knew GLP-1 drugs could cause dangerous intestinal slowing beyond the intended therapeutic effect. The distinction between "slowed digestion" (the desired effect) and "bowel obstruction" (a life-threatening emergency) was not adequately communicated to patients or prescribers.

Bowel obstruction often requires emergency hospitalization. Treatment may include nasogastric tube decompression, IV fluids, and in severe cases, surgical intervention to remove the obstruction or resect damaged bowel tissue. Patients who required emergency surgery have particularly strong claims.

Medical records documenting ER visits, imaging (X-ray or CT showing obstruction), surgical reports, and hospitalization are critical evidence. Even patients who were treated conservatively (without surgery) may have valid claims if they required hospitalization.